PUT - SPRINTER OPEN END - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 04:22:37 2024-06-04 EDT | ||
| 3.48 EUR | -0.29% |
|
| Current month | -2.51% | ||
| 1 month | +4.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 3.48 | -0.29% |
| 24-06-03 | 3.49 | -2.51% |
| 24-05-31 | 3.58 | -1.10% |
| 24-05-30 | 3.62 | -0.55% |
| 24-05-29 | 3.64 | +0.83% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 04:22 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV9GYE |
| ISIN | DE000VV9GYE7 |
| Date issued | 2022-11-10 |
| Strike | 79.84 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.67 € |
|---|---|
| Lowest since issue | 0.065 € |
| Spread | 0.02 € |
| Spread % | 0.57% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.77
USD
Average target price
53.19
USD
Spread / Average Target
+27.35%
- Stock Market
- Certificates
- Certificat
